A study published in the European Urology Oncology reports superior oncologic and safety benefits of adjuvant pembrolizumab compared with adjuvant tyrosine kinase inhibitors (TKIs) in patients treated with nephrectomy for...
Read More
Contributor Ted R. Mikuls, MD, MSPH, Umbach Professor of Rheumatology, Vice Chair for Research,...
Read More
It’s nearly impossible to avoid screen time these days; between smartphones, TVs, computers, and...
Read More
The presence of cardiovascular disease (CVD) comorbidities and type 2 diabetes (T2D) increased the...
Read More
The COVID-19 pandemic has proven to be especially traumatic for the elderly and those with chronic...
Read More
While most of us are now used to wearing face masks and social distancing, life during the...
Read More
Women with advanced/recurrent endometrial cancer, especially those with the non-endometrioid (type...
Read More
Pulmonary medicine consultation during hospital admission may impact management of critical asthma...
Read More
In children with severe asthma (SA), targeting small airways with high-dose inhaled...
Read More
During the past several weeks, the news about the US healthcare system has been dire. ICUs are at...
Read More
Contributor Elaine C. Siegfried, MD, Professor of Pediatrics and Dermatology, Saint Louis...
Read More
Foster score, a self-reported inhaled corticosteroid adherence score for patients with asthma,...
Read More
With some exceptions, people with asthma are not at a higher risk for more severe disease,...
Read MoreIbrutinib was associated with prolonged progression-free survival (PFS) compared to the chemoimmunotherapy regimen bendamustine plus rituximab in older patients with treatment-naïve chronic lymphocytic leukemia (CLL). In...
Read More
Eradicating Helicobacter pylori bacterium increases the morbidities of asthma and other allergic...
Read MoreAccording to published data, patients with mantle cell lymphoma (MCL), Waldenström macroglobulinemia (WM), marginal zone lymphoma (MZL), and chronic lymphocytic leukemia (CLL) experience frequent relapses over the course of...
Read MoreThe establishment of ibrutinib as a preferred first-line treatment option makes it important to understand the treatment sequence following first-line ibrutinib and the patient characteristics of those treated with a second-line...
Read MoreCurrently, the effect of the diagnosis-to-treatment interval (DTI) on survival in patients with mantle cell lymphoma (MCL) has not been extensively examined. Researchers aimed to determine the feasibility of active surveillance...
Read MoreThe combination of fludarabine, cyclophosphamide, and rituximab (FCR) is the only regimen other than allotransplantation shown in studies to result in a significant chance of functional cure in very long-term follow-up for...
Read More
The considerable commonalities between patients with obesity and Type 2 diabetes can be useful for...
Read More
